Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 5/2021

01-10-2021 | Lymphoma | Case Report

Synchronous gastric cancer and primary lymphoma of right adrenal gland: a case report

Authors: Shuichi Fukuda, Tomoko Wakasa, Hitoshi Hanamoto, Taichi Koyama, Yoshio Ohta, Masatoshi Inoue, Daisuke Terashita, Atsushi Gakuhara, Hideo Tomihara, Katsuya Ohta, Kotaro Kitani, Kazuhiko Hashimoto, Hajime Ishikawa, Jin-ichi Hida, Yutaka Kimura

Published in: Clinical Journal of Gastroenterology | Issue 5/2021

Login to get access

Abstract

This report presents an extremely rare case of synchronous gastric cancer and primary adrenal diffuse large B-cell lymphoma (DLBCL). An 82-year-old man underwent computed tomography, which revealed a heterogeneous appearing and hypodense adrenal mass and a gastric mass with no enlarged lymph nodes in the neck, mediastinum, abdomen, and inguinal region. Upper gastrointestinal endoscopy revealed a protruding gastric tumor. The specimens obtained from endoscopic biopsy were histologically confirmed to be adenocarcinoma. The hormonal findings eliminated functional adrenal tumor. The patient underwent distal gastrectomy with regional lymph node resection for gastric cancer and incisional biopsy of the adrenal mass. Based on the pathological findings, diagnoses of mixed mucinous and tubular adenocarcinomas of the stomach and adrenal DLBCL were confirmed. Postoperation, the patient received rituximab combined with low-dose doxorubicin, cyclophosphamide, vincristine, and prednisone (R-miniCHOP). Six courses of R-miniCHOP were planned, but were completed in only one course at the patient’s request. The patient died 2 months after surgery.
Literature
1.
go back to reference Li S, Wang Z, Wu Z, et al. Clinical characteristics and outcomes of primary adrenal diffuse large B cell lymphoma in a large contemporary cohort: a SEER-based analysis. Ann Hematol. 2019;98:2111–9.CrossRef Li S, Wang Z, Wu Z, et al. Clinical characteristics and outcomes of primary adrenal diffuse large B cell lymphoma in a large contemporary cohort: a SEER-based analysis. Ann Hematol. 2019;98:2111–9.CrossRef
2.
go back to reference Yang Y, Xie W, Ren Y, et al. A case report of primary adrenal lymphoma: a rare but aggressive and invasive disease. Medicine (Baltimore). 2020;99: e20938.CrossRef Yang Y, Xie W, Ren Y, et al. A case report of primary adrenal lymphoma: a rare but aggressive and invasive disease. Medicine (Baltimore). 2020;99: e20938.CrossRef
3.
go back to reference Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384:842–58.CrossRef Sehn LH, Salles G. Diffuse large B-cell lymphoma. N Engl J Med. 2021;384:842–58.CrossRef
4.
go back to reference Møller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol. 2004;124:151–9.CrossRef Møller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation—a population-based study of 1575 cases. Br J Haematol. 2004;124:151–9.CrossRef
5.
go back to reference Zhou Z, Sehn LH, Rademaker AW, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123:837–42.CrossRef Zhou Z, Sehn LH, Rademaker AW, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123:837–42.CrossRef
6.
go back to reference Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–97.CrossRef Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–97.CrossRef
7.
go back to reference Meng J, Pan H, Li X, et al. Diagnosis and treatment of synchronous lymphoma and digestive system carcinoma: report of four cases and literature review. Front Oncol. 2019;9:1367.CrossRef Meng J, Pan H, Li X, et al. Diagnosis and treatment of synchronous lymphoma and digestive system carcinoma: report of four cases and literature review. Front Oncol. 2019;9:1367.CrossRef
8.
go back to reference Nishino N, Konno H, Baba S, et al. Synchronous lymphoma and adenocarcinoma occurring as a collision tumor in the stomach: report of a case. Surg Today. 1996;26:508–12.CrossRef Nishino N, Konno H, Baba S, et al. Synchronous lymphoma and adenocarcinoma occurring as a collision tumor in the stomach: report of a case. Surg Today. 1996;26:508–12.CrossRef
9.
go back to reference Ishihama T, Kondo H, Saito D, et al. Clinicopathological studies on coexisting gastric malignant lymphoma and gastric adenocarcinoma: report of four cases and review of the Japanese literature. Jpn J Clin Oncol. 1997;27:101–6.CrossRef Ishihama T, Kondo H, Saito D, et al. Clinicopathological studies on coexisting gastric malignant lymphoma and gastric adenocarcinoma: report of four cases and review of the Japanese literature. Jpn J Clin Oncol. 1997;27:101–6.CrossRef
10.
go back to reference Matsushita M, Hajiro K, Okazaki K, et al. Simultaneous adenocarcinoma and malignant lymphoma of the stomach. Endoscopy. 1997;29:134.CrossRef Matsushita M, Hajiro K, Okazaki K, et al. Simultaneous adenocarcinoma and malignant lymphoma of the stomach. Endoscopy. 1997;29:134.CrossRef
11.
go back to reference Ueo T, Kashima K, Daa T, et al. Coexistence of Epstein-Barr virus-associated gastric carcinoma with malignant lymphoma: report of two cases. Virchows Arch. 2006;449:215–9.CrossRef Ueo T, Kashima K, Daa T, et al. Coexistence of Epstein-Barr virus-associated gastric carcinoma with malignant lymphoma: report of two cases. Virchows Arch. 2006;449:215–9.CrossRef
12.
go back to reference Trovato C, Sonzogni A, Ravizza D, et al. Confocal laser endomicroscopy diagnosis of gastric adenocarcinoma in a patient treated for gastric diffuse large-B-cell lymphoma. Dig Liver Dis. 2009;41:447–9.CrossRef Trovato C, Sonzogni A, Ravizza D, et al. Confocal laser endomicroscopy diagnosis of gastric adenocarcinoma in a patient treated for gastric diffuse large-B-cell lymphoma. Dig Liver Dis. 2009;41:447–9.CrossRef
13.
go back to reference Chong VH, Idros A, Telisinghe PU. Triple synchronous gastrointestinal malignancies: a rare occurrence. Singapore Med J. 2010;51:e176–8.PubMed Chong VH, Idros A, Telisinghe PU. Triple synchronous gastrointestinal malignancies: a rare occurrence. Singapore Med J. 2010;51:e176–8.PubMed
14.
go back to reference Casas CO, Guillén VV, Tarragó AC, et al. Synchronic gastric adenocarcinoma and lymphoma. Rev Esp Enferm Dig. 2011;103:388–9.CrossRef Casas CO, Guillén VV, Tarragó AC, et al. Synchronic gastric adenocarcinoma and lymphoma. Rev Esp Enferm Dig. 2011;103:388–9.CrossRef
15.
go back to reference Weng CH, Wang RC, Wu CC, et al. Treatment of synchronous adenocarcinoma and lymphoma of the stomach: a case report. Mol Clin Oncol. 2016;5:783–5.CrossRef Weng CH, Wang RC, Wu CC, et al. Treatment of synchronous adenocarcinoma and lymphoma of the stomach: a case report. Mol Clin Oncol. 2016;5:783–5.CrossRef
16.
go back to reference Fukunaga H, Asama H, Kaneda H, et al. Collision tumor with diffuse large B cell lymphoma and gastric cancer. Jpn J Clin Oncol. 2016;46:968–9.CrossRef Fukunaga H, Asama H, Kaneda H, et al. Collision tumor with diffuse large B cell lymphoma and gastric cancer. Jpn J Clin Oncol. 2016;46:968–9.CrossRef
17.
go back to reference Liu L, Zhao H, Sheng L, et al. Collision of lymphoepithelioma-like carcinoma with diffuse large B-cell lymphoma of the stomach: a case report. Anticancer Res. 2017;37:4569–73.CrossRef Liu L, Zhao H, Sheng L, et al. Collision of lymphoepithelioma-like carcinoma with diffuse large B-cell lymphoma of the stomach: a case report. Anticancer Res. 2017;37:4569–73.CrossRef
18.
go back to reference Carboni F, Diodoro MG, Valle M. Synchronous primary diffuse large B cell lymphoma and adenocarcinoma of the stomach: a clinical dilemma. Indian J Surg Oncol. 2020;11:S223–5.CrossRef Carboni F, Diodoro MG, Valle M. Synchronous primary diffuse large B cell lymphoma and adenocarcinoma of the stomach: a clinical dilemma. Indian J Surg Oncol. 2020;11:S223–5.CrossRef
19.
go back to reference Ma YH, Yamaguchi T, Yasumura T, et al. Pancreatic cancer secondary to intraductal papillary mucinous neoplasm with collision between gastric cancer and B-cell lymphoma: a case report. World J Clin Cases. 2021;9:2400–8.CrossRef Ma YH, Yamaguchi T, Yasumura T, et al. Pancreatic cancer secondary to intraductal papillary mucinous neoplasm with collision between gastric cancer and B-cell lymphoma: a case report. World J Clin Cases. 2021;9:2400–8.CrossRef
20.
go back to reference Hamaloglu E, Topaloglu S, Ozdemir A, et al. Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: a review of the literature. World J Gastroenterol. 2006;12:3564–74.CrossRef Hamaloglu E, Topaloglu S, Ozdemir A, et al. Synchronous and metachronous occurrence of gastric adenocarcinoma and gastric lymphoma: a review of the literature. World J Gastroenterol. 2006;12:3564–74.CrossRef
21.
go back to reference Namikawa T, Munekage E, Fukudome I, et al. Clinicopathological characteristics and therapeutic outcomes of synchronous gastric adenocarcinoma and gastric lymphoma. Anticancer Res. 2014;34:5067–74.PubMed Namikawa T, Munekage E, Fukudome I, et al. Clinicopathological characteristics and therapeutic outcomes of synchronous gastric adenocarcinoma and gastric lymphoma. Anticancer Res. 2014;34:5067–74.PubMed
22.
go back to reference Hu XR, Hu YX, Fu HR, et al. Diffuse large B-cell lymphoma with concurrent gastric adenocarcinoma: case report and literature review. J Int Med Res. 2011;39:2051–8.CrossRef Hu XR, Hu YX, Fu HR, et al. Diffuse large B-cell lymphoma with concurrent gastric adenocarcinoma: case report and literature review. J Int Med Res. 2011;39:2051–8.CrossRef
23.
go back to reference Chen DW, Pan Y, Yan JF, et al. Laparoscopic resection of synchronous gastric cancer and primary small intestinal lymphoma: a case report. World J Gastroenterol. 2014;20:6353–6.CrossRef Chen DW, Pan Y, Yan JF, et al. Laparoscopic resection of synchronous gastric cancer and primary small intestinal lymphoma: a case report. World J Gastroenterol. 2014;20:6353–6.CrossRef
24.
go back to reference Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601–10.CrossRef Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601–10.CrossRef
25.
26.
go back to reference Zhang Z, Wang L, Chen J, et al. Clinical analysis of adrenal lesions larger than 5 cm in diameter (an analysis of 251 cases). World J Surg Oncol. 2019;17:220.CrossRef Zhang Z, Wang L, Chen J, et al. Clinical analysis of adrenal lesions larger than 5 cm in diameter (an analysis of 251 cases). World J Surg Oncol. 2019;17:220.CrossRef
27.
go back to reference Rashidi A, Fisher SI. Primary adrenal lymphoma: a systemic review. Ann Hematol. 2013;92:1583–93.CrossRef Rashidi A, Fisher SI. Primary adrenal lymphoma: a systemic review. Ann Hematol. 2013;92:1583–93.CrossRef
28.
go back to reference Zerrweck C, Caiazzo R, Clerquin B, et al. Renal origin and size are independent predictors of survival after surgery for adrenal metastasis. Ann Surg Oncol. 2012;19:3621–6.CrossRef Zerrweck C, Caiazzo R, Clerquin B, et al. Renal origin and size are independent predictors of survival after surgery for adrenal metastasis. Ann Surg Oncol. 2012;19:3621–6.CrossRef
29.
go back to reference Igami T, Yamaguchi A, Isogai M, et al. A resected case of early gastric cancer with synchronous adrenal metastasis. Jpn J Cancer Clin. 1998;44:833–7 (In Japanese). Igami T, Yamaguchi A, Isogai M, et al. A resected case of early gastric cancer with synchronous adrenal metastasis. Jpn J Cancer Clin. 1998;44:833–7 (In Japanese).
30.
go back to reference Kosaka T, Ueshige N, Sugaya JI, et al. A long surviving case of resected gastric cancer presenting with a synchronous adrenal metastasis. Gastric Cancer. 1999;2:142–4.CrossRef Kosaka T, Ueshige N, Sugaya JI, et al. A long surviving case of resected gastric cancer presenting with a synchronous adrenal metastasis. Gastric Cancer. 1999;2:142–4.CrossRef
31.
go back to reference Wang J, Sun NC, Renslo R, et al. Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol. 1998;58:130–6.CrossRef Wang J, Sun NC, Renslo R, et al. Clinically silent primary adrenal lymphoma: a case report and review of the literature. Am J Hematol. 1998;58:130–6.CrossRef
32.
go back to reference Laurent C, Casasnovas O, Martin L, et al. Adrenal lymphoma: presentation, management and prognosis. QJM. 2017;110:103–9.PubMed Laurent C, Casasnovas O, Martin L, et al. Adrenal lymphoma: presentation, management and prognosis. QJM. 2017;110:103–9.PubMed
33.
go back to reference Majidi F, Martino S, Kondakci M, et al. Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study. Eur J Endocrinol. 2020;183:453–62.CrossRef Majidi F, Martino S, Kondakci M, et al. Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study. Eur J Endocrinol. 2020;183:453–62.CrossRef
34.
go back to reference McDonnell T, Mulkerrin E. Primary adrenal lymphoma. N Engl J Med. 2021;384:165.CrossRef McDonnell T, Mulkerrin E. Primary adrenal lymphoma. N Engl J Med. 2021;384:165.CrossRef
35.
go back to reference Peyrade F, Jardin F, Thieblemont C, et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2011;12:460–8.CrossRef Peyrade F, Jardin F, Thieblemont C, et al. Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2011;12:460–8.CrossRef
36.
go back to reference Schmitz N, Zeynalova S, Nickelsen M, et al. CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2016;34:3150–6.CrossRef Schmitz N, Zeynalova S, Nickelsen M, et al. CNS International Prognostic Index: a risk model for CNS relapse in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2016;34:3150–6.CrossRef
37.
go back to reference Harrysson S, Eloranta S, Ekberg S, et al. Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden. Blood Cancer J. 2021;11:9.CrossRef Harrysson S, Eloranta S, Ekberg S, et al. Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden. Blood Cancer J. 2021;11:9.CrossRef
Metadata
Title
Synchronous gastric cancer and primary lymphoma of right adrenal gland: a case report
Authors
Shuichi Fukuda
Tomoko Wakasa
Hitoshi Hanamoto
Taichi Koyama
Yoshio Ohta
Masatoshi Inoue
Daisuke Terashita
Atsushi Gakuhara
Hideo Tomihara
Katsuya Ohta
Kotaro Kitani
Kazuhiko Hashimoto
Hajime Ishikawa
Jin-ichi Hida
Yutaka Kimura
Publication date
01-10-2021

Other articles of this Issue 5/2021

Clinical Journal of Gastroenterology 5/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.